J Martin Carroll's Net Worth
$2.82 Million
Who is J Martin Carroll?
J Martin Carroll has an estimated net worth of $2.82 Million. This is based on reported shares across multiple companies, which include Catalent, Inc., INOTEK PHARMACEUTICALS CORP, Mallinckrodt plc, TherapeuticsMD, Inc., Durata Therapeutics, Inc., Esperion Therapeutics, Inc., VIVUS INC, and ACCREDO HEALTH INC.
SEC CIK
J Martin Carroll's CIK is 0001279901
Past Insider Trading and Trends
2016 was J Martin Carroll's most active year for acquiring shares with 9 total transactions. J Martin Carroll's most active month to acquire stocks was the month of April. 2019 was J Martin Carroll's most active year for disposing of shares, totalling 5 transactions. J Martin Carroll's most active month to dispose stocks was the month of February. 2004 saw J Martin Carroll paying a total of $975,275.23 for 34,111 shares, this is the most they've acquired in one year. In 2021 J Martin Carroll cashed out on 145,201 shares for a total of $437,455.77, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Catalent, Inc. (CTLT) Snapshot price: $56.64
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +33.18% | 6.99K |
—
|
—
| 28.07K |
Oct 27
| |||
Form 4
| +2.70% | 555 |
—
|
—
| 21.08K |
Jul 1
| |||
Form 4
| +25.34% | 4.15K |
—
|
—
| 20.52K |
Oct 27
| |||
Form 4
|
—
|
0
|
$134.12 |
—
| 28.04K |
Nov 29
| |||
Form 4
| +7.74% | 1.4K |
—
|
—
| 19.51K |
Oct 28
| |||
Form 4
| +13.30% | 2.13K |
—
|
—
| 18.11K |
Oct 29
| |||
Form 4
| +4.31% | 661 |
—
|
—
| 15.98K |
Aug 27
| |||
Form 4
|
—
|
0
|
$72.29 |
—
| 23.85K |
May 12
| |||
Form 4
| +20.10% | 3.17K |
—
|
—
| 18.92K |
Aug 22
| |||
Form 4
|
—
|
0
|
$53.24 |
—
| 20.68K |
Jul 15
| |||
Form 4
| +25.35% | 4.18K |
—
|
—
| 20.68K |
Aug 23
| |||
Form 4
| +31.75% | 3.98K |
—
|
—
| 16.5K |
Aug 24
| |||
Form 4
| +80.76% | 5.59K |
—
|
—
| 12.52K |
Aug 24
| |||
Form 4
| +76.37% | 3K |
$27.26 | $81,780.00 | 6.93K |
Sep 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INOTEK PHARMACEUTICALS CORP (RCKT) Snapshot price: $28.77
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
∞
| 10K |
$9.03 | $90,294.00 | 10K |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mallinckrodt plc (MNKTQ) Snapshot price: $0.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -42.06K |
$0.40 | -$16,855.45 |
0
|
Mar 12
| |||
Form 4
| -45.00% | -8.73K |
$2.96 | -$25,837.84 | 10.67K |
May 13
| |||
Form 4
|
—
|
0
|
$9.19 |
—
| 50.79K |
May 30
| |||
Form 4
| +55.92% | 10.87K |
$15.21 | -$129,695.67 | 30.31K |
May 15
| |||
Form 4
| +90.89% | 18.95K |
—
|
—
| 39.79K |
May 16
| |||
Form 4
| -11.00% | -2.58K |
$15.68 | -$40,391.68 | 20.85K |
Mar 1
| |||
Form 4
| +27.14% | 5K |
$20.42 | $102,093.50 | 23.42K |
Nov 9
| |||
Form 4
| -2.52% | -476.00 |
$37.37 | -$17,788.12 | 18.42K |
Oct 1
| |||
Form 4
| +22.04% | 3.44K |
$51.55 | -$117,843.30 | 19.03K |
Mar 1
| |||
Form 4
| +7.27% | 1.06K |
—
|
—
| 15.59K |
Oct 1
| |||
Form 4
| +7.68% | 1.04K |
—
|
—
| 14.54K |
Jul 21
| |||
Form 4
| +36.13% | 3.58K |
$55.69 | -$25,506.02 | 13.5K |
Mar 16
| |||
Form 4
| +7.68% | 707 |
$131.21 | -$132,259.68 | 9.92K |
Mar 19
| |||
Form 4
| +27.74% | 2K |
$69.24 | $138,480.00 | 9.21K |
Aug 12
| |||
Form 4
| +8.62% | 572 |
—
|
—
| 7.21K |
May 22
| |||
Form 4
| +31.84% | 1.6K |
$69.95 | -$67,921.45 | 6.64K |
Mar 20
| |||
Form 4
| +65.92% | 2K |
$51.27 | $102,540.00 | 5.03K |
Nov 26
| |||
Form 4
|
∞
| 3.03K |
—
|
—
| 3.03K |
Jul 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TherapeuticsMD, Inc. (TXMD) Snapshot price: $2.33
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +968.64% | 96.86K |
—
|
—
| 106.86K |
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
∞
| 10K |
$6.11 | $61,100.00 | 10K |
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Durata Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||